KEGG: ypn:YPN_3618
UspB belongs to the universal stress protein family, which mediates bacterial survival during nutrient deprivation, oxidative stress, and temperature fluctuations. In Y. pestis, UspB is upregulated under flea gut-mimicking conditions (25°C, microaerophilic environments) and during macrophage internalization . Experimental validation involves:
Transcriptomic profiling: RNA-seq of wild-type vs. ΔuspB strains exposed to 5 mM H₂O₂ for 1 hour reveals a 12-fold decrease in katY (catalase) expression in mutants .
Phenotypic assays: ΔuspB strains show 3.4× reduced survival in murine macrophages (J774A.1 cells) compared to wild-type .
Key parameters for recombinant UspB production in E. coli BL21(DE3):
| Parameter | Optimal Condition | Impact on Yield |
|---|---|---|
| Induction temperature | 18°C | Prevents inclusion body formation |
| IPTG concentration | 0.4 mM | Maximizes soluble protein |
| Lysis buffer | 50 mM Tris, 300 mM NaCl, 10 mM imidazole (pH 8.0) | Maintains protein stability |
Purification via Ni-NTA chromatography typically achieves >90% purity, confirmed by SDS-PAGE and Western blot using anti-His antibodies . LC-MS/MS validation identifies a 22 kDa band as full-length UspB with 98% sequence coverage .
Parallel serial passage experiments (PSPE) reveal:
Host-specific adaptation: After 750 generations in BALB/c mice, 8/12 Y. pestis populations developed non-synonymous mutations in uspB (G149D, A201V), increasing LD₅₀ by 4.2× .
Contradictory findings: In guinea pig models, the same mutations reduced persistence in spleen tissue by 67% (p < 0.01), suggesting host-specific selection pressures. Resolving this requires:
Robust approaches derived from Yersinia vaccine research :
| Blocking Factor | Rationale | Implementation Example |
|---|---|---|
| Age | Immune maturity differences | Use 6–8-week-old mice only |
| Circadian rhythm | Diurnal gene expression patterns | Standardize infection to ZT4 |
| Gut microbiota | Inter-individual colonization | Co-house animals pre-experiment |
Power analysis: For 80% power (α = 0.05) to detect a 2-fold change in bacterial load, n = 9/group is required, assuming σ = 0.8 log₁₀ CFU .
Validation workflow:
Epitope mapping: Anti-UspB antibodies (e.g., Santa Cruz Biotechnology YPF19) bind residues 78–112, confirmed by peptide microarray .
Knockout validation: Western blot using ΔuspB lysate eliminates signal at 22 kDa .
Functional assays: Recombinant UspB restores thermotolerance in ΔuspB strains (45°C survival: 41% vs. 8% in controls) .
Conflicting reports arise from:
Stressor concentration: 5 mM vs. 10 mM H₂O₂ yields opposite uspB expression trends (RNA-seq FPKM: 152 vs. 48) .
Growth phase: Stationary-phase cells show 3.7× higher UspB levels than log-phase (qPCR ΔΔCt = -4.2) .
Solution: Standardize to mid-log phase (OD₆₀₀ = 0.6) and 2 mM H₂O₂ for 30 minutes.
Successful crystallization conditions:
| Condition | Composition | Crystal Resolution |
|---|---|---|
| Hanging drop | 0.1 M HEPES (pH 7.5), 2.0 M ammonium sulfate | 2.4 Å |
| Microbatch | 20% PEG 3350, 0.2 M sodium citrate | 3.1 Å |
Add 5 mM ATP to crystallization drops to stabilize the ATP-binding pocket .